Mission & Vision

ProteomTech's mission is to develop new protein therapeutics for treating illness, improving health, and extending longevity.

ProteomTech, Inc. (PTI) is an emerging product-driven drug development company focusing on developing and producing therapeutic proteins through optimally refolding E. coli inclusion bodies that are difficult to recover by competing technologies. Using its robust, patented protein refolding technology, the Pt-Fold technology, PTI has developed a pipeline of new protein drugs. In addition, PTI is using its China facility for accelerated drug approval and marketing in China, in turn quickly validate the clinical development investment in the US and world market.

PTI has also developed an automated protein refolding system using the core Pt-Fold technology. The automated system is capable of producing a large number of biologically active human proteins at low cost and with high throughput. The automated refolding system enables PTI to serve its customers with high efficiency and low cost.

ProteomTech Staff
 
FOR SALE: Difficult and Medically Important Proteins

FOR SALE: Difficult and
Medically Important Proteins.

BREAKING NEWS:
ProteomTech, Inc. and
Collaborators Make Major Breakthrough
in Stem Cell Research

View a technical animation about our high throughput protein refolding technology.

View a technical animation about our high throughput protein refolding technology.

Quicktime | Win Media
Find out why many top pharmaceutical companies are working with us

Find out why many top
pharmaceutical companies are working with us.